<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font21 { font-size : 21; } .font27 { font-size : 27; } .font28 { font-size : 28; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">;():–. </span>
   <span class="font28">HAdV </span>
   <span class="font28">adenoviral </span>
   <span class="font27">treatment </span>
   <span class="font21">ocular </span>
   <span class="font19">adenovirus </span>
   <span class="font19">viral </span>
   <span class="font18">topical </span>
   <span class="font17">antiviral </span>
   <span class="font16">PVI </span>
   <span class="font16">keratoconjunctivitis. </span>
   <span class="font16">use </span>
   <span class="font15">infection </span>
   <span class="font15">clinical </span>
   <span class="font15">significant </span>
   <span class="font15">ophthalmic </span>
   <span class="font14">corneal </span>
   <span class="font14">keratoconjunctivitis </span>
   <span class="font14">Ophthalmol. </span>
   <span class="font14">effective </span>
   <span class="font14">infection. </span>
   <span class="font14">patients </span>
   <span class="font14">{border-style </span>
   <span class="font14">acute </span>
   <span class="font13">associated </span>
   <span class="font13">cell </span>
   <span class="font13">cells </span>
   <span class="font13">cyclosporine </span>
   <span class="font13">px;} </span>
   <span class="font13">#ffffff;} </span>
   <span class="font13">cases </span>
   <span class="font13">effects </span>
   <span class="font13">efficacy </span>
   <span class="font13">human </span>
   <span class="font13">replication </span>
   <span class="font13">risk </span>
   <span class="font13">subepithelial </span>
   <span class="font13">type </span>
   <span class="font13">Topical </span>
   <span class="font13">activity </span>
   <span class="font13">cidofovir </span>
   <span class="font13">eye </span>
   <span class="font13">potential </span>
   <span class="font13">study </span>
   <span class="font12">DNA </span>
   <span class="font12">Group </span>
   <span class="font12">SEIs </span>
   <span class="font12">cause </span>
   <span class="font12">conjunctivitis </span>
   <span class="font12">epidemic </span>
   <span class="font12">immunocompromised </span>
   <span class="font12">infections </span>
   <span class="font12">infiltrates </span>
   <span class="font12">management </span>
   <span class="font12">shown </span>
   <span class="font12">tacrolimus </span>
   <span class="font12">;:–. </span>
   <span class="font12">effect </span>
   <span class="font12">individuals </span>
   <span class="font12">therapeutic </span>
   <span class="font12">types </span>
   <span class="font12">Antiviral </span>
   <span class="font12">GCV </span>
   <span class="font12">anti-inflammatory </span>
   <span class="font12">challenge </span>
   <span class="font12">host </span>
   <span class="font12">iodine </span>
   <span class="font12">latent </span>
   <span class="font12">persistent </span>
   <span class="font12">phase </span>
   <span class="font12">povidone-iodine </span>
   <span class="font12">respiratory </span>
   <span class="font12">Clin </span>
   <span class="font12">combination </span>
   <span class="font12">demonstrated </span>
   <span class="font12">drugs </span>
   <span class="font12">solution </span>
   <span class="font12">systemic </span>
   <span class="font12">transmission </span>
   <span class="font12">used </span>
   <span class="font11">CDV </span>
   <span class="font11">EKC </span>
   <span class="font11">Infect </span>
   <span class="font11">Res. </span>
   <span class="font11">corticosteroid </span>
   <span class="font11">disease, </span>
   <span class="font11">dissemination </span>
   <span class="font11">immune </span>
   <span class="font11">infection, </span>
   <span class="font11">infections. </span>
   <span class="font11">irrigation </span>
   <span class="font11">likely </span>
   <span class="font11">long-term </span>
   <span class="font11">lymphoid </span>
   <span class="font11">therapy </span>
   <span class="font11">toxicity </span>
   <span class="font11">Additionally, </span>
   <span class="font11">Cornea. </span>
   <span class="font11">Virol. </span>
   <span class="font11">adenoviruses </span>
   <span class="font11">artificial </span>
   <span class="font11">development </span>
   <span class="font11">drops </span>
   <span class="font11">drug </span>
   <span class="font11">high </span>
   <span class="font11">inflammatory </span>
   <span class="font11">keratoconjunctivitis, </span>
   <span class="font11">persistence </span>
   <span class="font11">px; </span>
   <span class="font11">rabbit </span>
   <span class="font11">response </span>
   <span class="font11">severe </span>
   <span class="font11">surface </span>
   <span class="font11">symptoms </span>
   <span class="font11">tissue </span>
   <span class="font11">using </span>
   <span class="font11">virus </span>
   <span class="font11">{font-family </span>
   <span class="font11">Furthermore, </span>
   <span class="font11">However, </span>
   <span class="font11">cellular </span>
   <span class="font11">conjunctivitis. </span>
   <span class="font11">doi:./S-()- </span>
   <span class="font11">epithelial </span>
   <span class="font11">following </span>
   <span class="font11">font-size </span>
   <span class="font11">important </span>
   <span class="font11">include </span>
   <span class="font11">infected </span>
   <span class="font11">inhibits </span>
   <span class="font11">keratitis, </span>
   <span class="font11">particularly </span>
   <span class="font11">prophylactic </span>
   <span class="font11">proven </span>
   <span class="font11">reduce </span>
   <span class="font11">reduction </span>
   <span class="font11">results </span>
   <span class="font11">safety </span>
   <span class="font11">steroid </span>
   <span class="font11">tears </span>
   <span class="font11">transplant </span>
   <span class="font11">visual </span>
   <span class="font11">Adenovirus </span>
   <span class="font11">Cyclosporine </span>
   <span class="font11">Eye </span>
   <span class="font11">Ganciclovir </span>
   <span class="font11">HAdV, </span>
   <span class="font11">New </span>
   <span class="font11">Ophthalmol </span>
   <span class="font11">Sci. </span>
   <span class="font11">acid </span>
   <span class="font11">active </span>
   <span class="font11">addition </span>
   <span class="font11">administered </span>
   <span class="font11">agent </span>
   <span class="font11">animal </span>
   <span class="font11">brincidofovir </span>
   <span class="font11">clinically </span>
   <span class="font11">complications </span>
   <span class="font11">conjunctiva </span>
   <span class="font11">conjunctival </span>
   <span class="font11">conjunctivitis, </span>
   <span class="font11">consideration </span>
   <span class="font11">corticosteroids </span>
   <span class="font11">dexamethasone </span>
   <span class="font11">disease </span>
   <span class="font11">disinfection </span>
   <span class="font11">doi:./.. </span>
   <span class="font11">double; </span>
   <span class="font11">favorable </span>
   <span class="font11">in-office </span>
   <span class="font11">including </span>
   <span class="font11">inhibiting </span>
   <span class="font11">lead </span>
   <span class="font11">limited </span>
   <span class="font11">mucosal </span>
   <span class="font11">multiple </span>
   <span class="font11">new </span>
   <span class="font11">polymerase </span>
   <span class="font11">propensity </span>
   <span class="font11">reactivation </span>
   <span class="font11">reducing </span>
   <span class="font11">research </span>
   <span class="font11">resolution </span>
   <span class="font11">review </span>
   <span class="font11">role </span>
   <span class="font11">secondary </span>
   <span class="font11">shedding </span>
   <span class="font11">specifically </span>
   <span class="font11">stem </span>
   <span class="font11">steroids </span>
   <span class="font11">such, </span>
   <span class="font11">treat </span>
   <span class="font11">use. </span>
   <span class="font11">virus, </span>
   <span class="font11">;:. </span>
   <span class="font11">Brincidofovir </span>
   <span class="font11">Challenges </span>
   <span class="font11">Cidofovir </span>
   <span class="font11">EKC. </span>
   <span class="font11">Epidemic </span>
   <span class="font11">Human </span>
   <span class="font11">Int </span>
   <span class="font11">Invest </span>
   <span class="font11">PVI/dexamethasone </span>
   <span class="font11">Ther. </span>
   <span class="font11">Transplant. </span>
   <span class="font11">Vis </span>
   <span class="font11">ability </span>
   <span class="font11">agents </span>
   <span class="font11">antimicrobial </span>
   <span class="font11">benefit </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">cataract </span>
   <span class="font11">chronic </span>
   <span class="font11">complications. </span>
   <span class="font11">controlled </span>
   <span class="font11">early </span>
   <span class="font11">effects. </span>
   <span class="font11">future </span>
   <span class="font11">gastrointestinal </span>
   <span class="font11">hematopoietic </span>
   <span class="font11">however, </span>
   <span class="font11">immunocompetent </span>
   <span class="font11">inhibition </span>
   <span class="font11">investigation </span>
   <span class="font11">men </span>
   <span class="font11">model. </span>
   <span class="font11">models. </span>
   <span class="font11">necessary </span>
   <span class="font11">need </span>
   <span class="font11">note </span>
   <span class="font11">pathogen </span>
   <span class="font11">patients. </span>
   <span class="font11">pediatric </span>
   <span class="font11">prevent </span>
   <span class="font11">profile </span>
   <span class="font11">prophylaxis </span>
   <span class="font11">pseudomembrane </span>
   <span class="font11">require </span>
   <span class="font11">resistant </span>
   <span class="font11">shedding. </span>
   <span class="font11">solid; </span>
   <span class="font11">tract </span>
   <span class="font11">tract, </span>
   <span class="font11">treating </span>
   <span class="font11">trial </span>
   <span class="font11">urethritis </span>
   <span class="font11">versus </span>
   <span class="font11">vitro </span>
   <span class="font11">work </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font10">.GordonYJ, </span>
   <span class="font10">.RomanowskiEG, </span>
   <span class="font10">Arch </span>
   <span class="font10">Clinical </span>
   <span class="font10">Dis. </span>
   <span class="font10">Drug </span>
   <span class="font10">FDA-approved </span>
   <span class="font10">GIT </span>
   <span class="font10">HAdV. </span>
   <span class="font10">Immunol. </span>
   <span class="font10">Infect. </span>
   <span class="font10">Labib </span>
   <span class="font10">Management </span>
   <span class="font10">Microbiol </span>
   <span class="font10">Ocul </span>
   <span class="font10">RomanowskiEG, </span>
   <span class="font10">SEIs, </span>
   <span class="font10">Therapy </span>
   <span class="font10">Treatment </span>
   <span class="font10">YatesKA, </span>
   <span class="font10">Zealand </span>
   <span class="font10">adenoid </span>
   <span class="font10">affected </span>
   <span class="font10">affecting </span>
   <span class="font10">and, </span>
   <span class="font10">anti-adenoviral </span>
   <span class="font10">antiseptic </span>
   <span class="font10">asymptomatic </span>
   <span class="font10">bold </span>
   <span class="font10">burden </span>
   <span class="font10">cases. </span>
   <span class="font10">cells. </span>
   <span class="font10">chain </span>
   <span class="font10">common </span>
   <span class="font10">compared </span>
   <span class="font10">comparison </span>
   <span class="font10">concentrations </span>
   <span class="font10">considered </span>
   <span class="font10">control </span>
   <span class="font10">cornea </span>
   <span class="font10">courier; </span>
   <span class="font10">current </span>
   <span class="font10">cyclosporin </span>
   <span class="font10">cytokines </span>
   <span class="font10">decrease </span>
   <span class="font10">decreased </span>
   <span class="font10">diclofenac </span>
   <span class="font10">different </span>
   <span class="font10">discussed </span>
   <span class="font10">disseminated </span>
   <span class="font10">doi:./ </span>
   <span class="font10">doi:./-- </span>
   <span class="font10">doi:./s--- </span>
   <span class="font10">duration </span>
   <span class="font10">economic </span>
   <span class="font10">elevated </span>
   <span class="font10">em; </span>
   <span class="font10">evaluation </span>
   <span class="font10">eyelid </span>
   <span class="font10">form </span>
   <span class="font10">forms </span>
   <span class="font10">formulations </span>
   <span class="font10">free </span>
   <span class="font10">ganciclovir </span>
   <span class="font10">gel </span>
   <span class="font10">immunosuppressive </span>
   <span class="font10">increased </span>
   <span class="font10">infect </span>
   <span class="font10">infections, </span>
   <span class="font10">infectious </span>
   <span class="font10">inflammation, </span>
   <span class="font10">inhibit </span>
   <span class="font10">interferon </span>
   <span class="font10">involves </span>
   <span class="font10">known </span>
   <span class="font10">limit </span>
   <span class="font10">low </span>
   <span class="font10">management. </span>
   <span class="font10">modalities </span>
   <span class="font10">models, </span>
   <span class="font10">outbreaks </span>
   <span class="font10">patient </span>
   <span class="font10">pilot </span>
   <span class="font10">possible </span>
   <span class="font10">prednisolone </span>
   <span class="font10">present </span>
   <span class="font10">primary </span>
   <span class="font10">properties </span>
   <span class="font10">pt;} </span>
   <span class="font10">punctate </span>
   <span class="font10">randomized </span>
   <span class="font10">rate </span>
   <span class="font10">reduced </span>
   <span class="font10">reported </span>
   <span class="font10">resistance </span>
   <span class="font10">saline </span>
   <span class="font10">serve </span>
   <span class="font10">sialic </span>
   <span class="font10">signaling </span>
   <span class="font10">significantly </span>
   <span class="font10">spread </span>
   <span class="font10">standard </span>
   <span class="font10">studies </span>
   <span class="font10">study. </span>
   <span class="font10">subtypes </span>
   <span class="font10">suggested </span>
   <span class="font10">target </span>
   <span class="font10">transfer </span>
   <span class="font10">utilizing </span>
   <span class="font10">various </span>
   <span class="font10">vernal </span>
   <span class="font10">virucidal </span>
   <span class="font10">virus. </span>
   <span class="font10">viruses </span>
   <span class="font10">vitro. </span>
   <span class="font10">wound </span>
  </p>
 </body>
</html>
